Fetal Medicine: New Insight and Future Direction

Dear Colleagues,

Our understanding of the molecular pathology of pregnancy, including perinatal and maternal health, has grown steadily with the progressive development of noninvasive tools, such as liquid biopsies using maternal blood samples that contain perinatal health information. The collection of genomics, transcriptomics, proteomics, and metabolomics data from these samples and other samples has necessitated new statistical approaches that include machine learning and artificial intelligence to infer clinically relevant information, such as biomarker discovery. This technology revolution has been especially helpful in understanding black box disorders of pregnancy affecting both mother and fetus across the 1st, 2nd, and 3rd trimesters, which now may also be addressed by spatial transcriptomics. This Special Issue seeks manuscripts relating to the early pathology of disorders, such as spontaneous preterm birth, early-onset pre-eclampsia, fetal hypoxia, and poor growth, that are discoverable and may potentially serve as markers leading to the development of early screening tests enabling the ultimate goal of preventing rather than treating these clinical diseases.

Prof. Dr. Carl Weiner
Prof. Dr. Judith Klein-Seetharaman
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.